Hospira ($HSP) plans to invest $120 million in its McPherson, Kansas, production plant over the next 5 years, with the money going towards additional production lines and automated visual inspection systems. Article
Editor's note: An earlier version of this article incorrectly said FDA issued a warning letter to the McPherson plant in 2010. The error has been removed.